Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Charles River Laboratories International, Inc., commonly known as Charles River, is a leading provider of essential products and services for the pharmaceutical and biotechnology industries. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, offering a global reach that enhances its service delivery.
Founded in 1947, Charles River has achieved significant milestones, including the expansion of its preclinical and clinical services. The company specialises in drug discovery, safety assessment, and laboratory services, providing unique solutions that streamline the research process. Its commitment to innovation and quality has solidified its position as a trusted partner in the life sciences sector.
With a robust portfolio that includes in vivo and in vitro testing, Charles River Laboratories is recognised for its expertise and reliability, making it a preferred choice for organisations seeking to advance their research and development efforts.
+35 vs industry average
Charles River Laboratories’s score of 65 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
In 2025, Charles River Laboratories reported total greenhouse gas emissions of approximately 450,000,000 kg CO2e. This total includes about 82,825,000 kg CO2e from Scope 1 and 2 emissions combined, and approximately 367,713,000 kg CO2e from Scope 3 emissions, which encompasses a range of activities including purchased goods and services, employee commuting, and business travel.
The company has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 50% from a 2018 baseline by the year 2030. Additionally, Charles River Laboratories is targeting a 15% reduction in absolute Scope 3 emissions from a 2019 baseline by 2030. As of 2023, the company has reported that it is on track to meet 37% of its Scope 1 and 2 reduction goal.
Charles River Laboratories is also committed to increasing its annual sourcing of renewable electricity from 1% in 2018 to 100% by 2030, aligning with industry standards for sustainability and climate action. These targets are consistent with the Science Based Targets initiative (SBTi) and reflect the company's commitment to reducing its carbon footprint in line with global climate goals.
Access structured emission data, company specific factors and auditable source documents
2030
15% reduction in scope 3 total
Charles River Laboratories, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 50% by 2030 from a 2018 base year. Charles River Lab…
2030
50% reduction in Scope 2
Charles River Laboratories, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 50% by 2030 from a 2018 base year. Charles River Lab…
2030
50% reduction in Scope 1
Charles River Laboratories, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 50% by 2030 from a 2018 base year. Charles River Lab…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


Common questions about Charles River Laboratories’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more